Skip to main content
Erschienen in: Obesity Surgery 6/2021

18.02.2021 | Original Contributions

Comparative Effectiveness of Roux-en-Y Gastric Bypass vs. One Anastomosis Gastric Bypass on Kidney Function

verfasst von: Mohsen Mahmoudieh, Behrouz Keleidari, Pedram Hadipour, Erfan Sheikhbahaei, Alex R. Chang, Sina Ramtin, Shahab Shahabi

Erschienen in: Obesity Surgery | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Obesity and its associated medical problems increase risk of kidney function decline while prior studies suggest that bariatric surgery may improve kidney outcomes. However, little is known about the comparative effectiveness of different types of bariatric surgery on kidney function. In this study, we compare the effects of laparoscopic one anastomosis gastric bypass (LOAGB) and laparoscopic Roux-en-Y gastric bypass (LRYGB) on kidney function one year after surgery.

Materials and Methods

The patients’ demographic, medical, and surgical data were prospectively collected and retrospectively reviewed. Type 2 diabetes mellitus, hypertension, and dyslipidemia, body mass index (BMI), and kidney function tests were obtained before and one year after surgery. Kidney function was evaluated by estimated glomerular filtration rate (eGFR) and spot urine albumin to creatinine ratio (ACR). Changes in eGFR and ACR were compared between LRYGB vs. LOAGB after adjustment for confounders (age, sex, remission of associated medical problems, preoperative BMI, and percentage of excess BMI loss) using ANCOVA model.

Results

Both surgical techniques significantly decreased the post-surgery presence of diabetes, hypertension, and dyslipidemia (p < 0.001 for all paired comparisons). The eGFR level significantly increased and the ACR level significantly decreased in both groups (p < 0.001 for all paired comparisons before and after adjustment). However, eGFR and ACR mean differences between LRYGB and LOAGB were not significantly different after adjustment for confounding variables (p = 0.9 and 0.4, respectively).

Conclusion

Both LOAGB and LRYGB improved 1-year eGFR and ACR equally independently from weight loss and other confounders.
Literatur
2.
Zurück zum Zitat Sayadi Shahraki M, Khalili N, Yousefvand S, Sheikhbahaei E, Shahabi Shahmiri S. Severe obesity and vitamin D deficiency treatment options before bariatric surgery: a randomized clinical trial. Surg Obes Relat Dis. Elsevier Inc.; 2019;15:1604–11. Available from: https://doi.org/10.1016/j.soard.2019.05.033. Sayadi Shahraki M, Khalili N, Yousefvand S, Sheikhbahaei E, Shahabi Shahmiri S. Severe obesity and vitamin D deficiency treatment options before bariatric surgery: a randomized clinical trial. Surg Obes Relat Dis. Elsevier Inc.; 2019;15:1604–11. Available from: https://​doi.​org/​10.​1016/​j.​soard.​2019.​05.​033.
4.
Zurück zum Zitat Rahmani A, Sayehmiri K, Asadollahi K, et al. Investigation of the prevalence of obesity in Iran: a systematic review and meta-analysis study. Acta Med Iran. 2015;53:596–607.PubMed Rahmani A, Sayehmiri K, Asadollahi K, et al. Investigation of the prevalence of obesity in Iran: a systematic review and meta-analysis study. Acta Med Iran. 2015;53:596–607.PubMed
5.
Zurück zum Zitat Afshin A, Forouzanfar MH, Reitsma MB, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13–27.CrossRef Afshin A, Forouzanfar MH, Reitsma MB, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13–27.CrossRef
6.
Zurück zum Zitat Holcomb CN, Goss LE, Almehmi A, et al. Bariatric surgery is associated with renal function improvement. Surg Endosc. Springer US. 2018;32:276–81.CrossRef Holcomb CN, Goss LE, Almehmi A, et al. Bariatric surgery is associated with renal function improvement. Surg Endosc. Springer US. 2018;32:276–81.CrossRef
7.
Zurück zum Zitat Chang AR, Grams ME, Ballew SH, et al. Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium. BMJ. 2019;364 Chang AR, Grams ME, Ballew SH, et al. Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium. BMJ. 2019;364
8.
Zurück zum Zitat Schiavon CA, Bersch-Ferreira AC, Santucci EV, et al. Effects of bariatric surgery in obese patients with hypertension the GATEWAY randomized trial (gastric bypass to treat obese patients with steady hypertension). Circulation. 2018;137:1132–42.CrossRef Schiavon CA, Bersch-Ferreira AC, Santucci EV, et al. Effects of bariatric surgery in obese patients with hypertension the GATEWAY randomized trial (gastric bypass to treat obese patients with steady hypertension). Circulation. 2018;137:1132–42.CrossRef
9.
Zurück zum Zitat Schiavon CA, Bhatt DL, Ikeoka D, et al. Three-year outcomes of bariatric surgery in patients with obesity and hypertension: a randomized clinical trial. Ann Intern Med. 2020;173:685–93.CrossRef Schiavon CA, Bhatt DL, Ikeoka D, et al. Three-year outcomes of bariatric surgery in patients with obesity and hypertension: a randomized clinical trial. Ann Intern Med. 2020;173:685–93.CrossRef
10.
11.
Zurück zum Zitat D’Agati VD, Chagnac A, De Vries APJ, Levi M, Porrini E, Herman-Edelstein M, et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol. Nature Publishing Group; 2016;12:453–71. Available from: https://doi.org/10.1038/nrneph.2016.75. D’Agati VD, Chagnac A, De Vries APJ, Levi M, Porrini E, Herman-Edelstein M, et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol. Nature Publishing Group; 2016;12:453–71. Available from: https://​doi.​org/​10.​1038/​nrneph.​2016.​75.
12.
Zurück zum Zitat Cohen RV, Pereira TV, Aboud CM, et al. Microvascular Outcomes after Metabolic Surgery (MOMS) in patients with type 2 diabetes mellitus and class I obesity: rationale and design for a randomised controlled trial. BMJ Open. 2017;7:e013574.CrossRef Cohen RV, Pereira TV, Aboud CM, et al. Microvascular Outcomes after Metabolic Surgery (MOMS) in patients with type 2 diabetes mellitus and class I obesity: rationale and design for a randomised controlled trial. BMJ Open. 2017;7:e013574.CrossRef
13.
Zurück zum Zitat Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019;393:1299–309.CrossRef Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019;393:1299–309.CrossRef
14.
Zurück zum Zitat Cohen RV, Pereira TV, Aboud CM, et al. Effect of gastric bypass vs best medical treatment on early-stage chronic kidney disease in patients with type 2 diabetes and obesity: a randomized clinical trial. JAMA Surg. 2020;155:1–11.CrossRef Cohen RV, Pereira TV, Aboud CM, et al. Effect of gastric bypass vs best medical treatment on early-stage chronic kidney disease in patients with type 2 diabetes and obesity: a randomized clinical trial. JAMA Surg. 2020;155:1–11.CrossRef
16.
Zurück zum Zitat Park S, Kim YJ, Choi CY, et al. Bariatric surgery can reduce albuminuria in patients with severe obesity and normal kidney function by reducing systemic inflammation. Obes Surg. 2018;28:831–7.CrossRef Park S, Kim YJ, Choi CY, et al. Bariatric surgery can reduce albuminuria in patients with severe obesity and normal kidney function by reducing systemic inflammation. Obes Surg. 2018;28:831–7.CrossRef
17.
Zurück zum Zitat Magalhães DSC, Pedro JMP, Souteiro PEB, et al. Analyzing the impact of bariatric surgery in kidney function: a 2-year observational study. Obes Surg. 2019;29:197–206.CrossRef Magalhães DSC, Pedro JMP, Souteiro PEB, et al. Analyzing the impact of bariatric surgery in kidney function: a 2-year observational study. Obes Surg. 2019;29:197–206.CrossRef
20.
Zurück zum Zitat Carbajo MA, Luque-de-León E, Jiménez JM, et al. Laparoscopic one-anastomosis gastric bypass: technique, results, and long-term follow-up in 1200 patients. Obes Surg. 2017;27:1153–67.CrossRef Carbajo MA, Luque-de-León E, Jiménez JM, et al. Laparoscopic one-anastomosis gastric bypass: technique, results, and long-term follow-up in 1200 patients. Obes Surg. 2017;27:1153–67.CrossRef
21.
Zurück zum Zitat Lee WJ, Ser KH, Lee YC, et al. Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012;22:1827–34.CrossRef Lee WJ, Ser KH, Lee YC, et al. Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012;22:1827–34.CrossRef
22.
Zurück zum Zitat Spivak H, Munz Y, Rubin M, Raz I, Shohat T, Blumenfeld O. Omega-loop gastric bypass is more effective for weight loss but negatively impacts liver enzymes: a registry-based comprehensive first-year analysis. Surg Obes Relat Dis. Elsevier Inc.; 2018;14:175–80. Available from: https://doi.org/10.1016/j.soard.2017.11.006. Spivak H, Munz Y, Rubin M, Raz I, Shohat T, Blumenfeld O. Omega-loop gastric bypass is more effective for weight loss but negatively impacts liver enzymes: a registry-based comprehensive first-year analysis. Surg Obes Relat Dis. Elsevier Inc.; 2018;14:175–80. Available from: https://​doi.​org/​10.​1016/​j.​soard.​2017.​11.​006.
23.
Zurück zum Zitat Garcia MS, Calderoni DR, Jimenez LS, et al. Renal function 1 year after bariatric surgery: influence of Roux-en-Y gastric bypass and identification of pre-operative predictors of improvement. Obes Surg. 2020;30:860–6.CrossRef Garcia MS, Calderoni DR, Jimenez LS, et al. Renal function 1 year after bariatric surgery: influence of Roux-en-Y gastric bypass and identification of pre-operative predictors of improvement. Obes Surg. 2020;30:860–6.CrossRef
24.
Zurück zum Zitat Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–76.CrossRef Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–76.CrossRef
26.
Zurück zum Zitat Magouliotis DE, Tasiopoulou VS, Tzovaras G. One anastomosis gastric bypass versus Roux-en-Y gastric bypass for morbid obesity: an updated meta-analysis. Obes Surg. 2019;29:2721–30.CrossRef Magouliotis DE, Tasiopoulou VS, Tzovaras G. One anastomosis gastric bypass versus Roux-en-Y gastric bypass for morbid obesity: an updated meta-analysis. Obes Surg. 2019;29:2721–30.CrossRef
27.
Zurück zum Zitat Magouliotis DE, Tasiopoulou VS, Tzovaras G. One anastomosis gastric bypass versus Roux-en-Y gastric bypass for morbid obesity: a meta-analysis. Clin Obes. 2018;8:159–69.CrossRef Magouliotis DE, Tasiopoulou VS, Tzovaras G. One anastomosis gastric bypass versus Roux-en-Y gastric bypass for morbid obesity: a meta-analysis. Clin Obes. 2018;8:159–69.CrossRef
28.
Zurück zum Zitat Keleidari B, Mahmoudieh M, Shahabi S, Sheikhbahaei E, Rezaei M, Sayadi M, et al. Reversing one-anastomosis gastric bypass surgery due to severe and refractory hypoalbuminemia. World J Surg. Springer International Publishing; 2020;44:1200–8. Available from: https://doi.org/10.1007/s00268-019-05290-7. Keleidari B, Mahmoudieh M, Shahabi S, Sheikhbahaei E, Rezaei M, Sayadi M, et al. Reversing one-anastomosis gastric bypass surgery due to severe and refractory hypoalbuminemia. World J Surg. Springer International Publishing; 2020;44:1200–8. Available from: https://​doi.​org/​10.​1007/​s00268-019-05290-7.
29.
Zurück zum Zitat Keleidari B, Mahmoudieh M, Gorgi K, et al. Hepatic failure after bariatric surgery: a systematic review. Hepat Mon. 2019;19:1–16. Keleidari B, Mahmoudieh M, Gorgi K, et al. Hepatic failure after bariatric surgery: a systematic review. Hepat Mon. 2019;19:1–16.
30.
Zurück zum Zitat Ruiz-Tovar J, Carbajo MA, Jimenez JM, Castro MJ, Gonzalez G, Ortiz-de-Solorzano J, et al. Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities. Surg Endosc. Springer US; 2019;33:401–10. Available from: https://doi.org/10.1007/s00464-018-6307-9. Ruiz-Tovar J, Carbajo MA, Jimenez JM, Castro MJ, Gonzalez G, Ortiz-de-Solorzano J, et al. Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities. Surg Endosc. Springer US; 2019;33:401–10. Available from: https://​doi.​org/​10.​1007/​s00464-018-6307-9.
32.
Zurück zum Zitat Choudhury RA, Hoeltzel G, Prins K, et al. Sleeve gastrectomy compared with gastric bypass for morbidly obese patients with end stage renal disease: a decision analysis. J Gastrointest Surg. 2020;24:756–63.CrossRef Choudhury RA, Hoeltzel G, Prins K, et al. Sleeve gastrectomy compared with gastric bypass for morbidly obese patients with end stage renal disease: a decision analysis. J Gastrointest Surg. 2020;24:756–63.CrossRef
33.
Zurück zum Zitat Bassiony AI, Sabry A, Shiha O, et al. The short-term renal effects of bariatric surgery: a comparative study between sleeve gastrectomy and one anastomosis gastric bypass operations among Egyptian patients with severe obesity. Obes Surg. 2020;30:4494–504.CrossRef Bassiony AI, Sabry A, Shiha O, et al. The short-term renal effects of bariatric surgery: a comparative study between sleeve gastrectomy and one anastomosis gastric bypass operations among Egyptian patients with severe obesity. Obes Surg. 2020;30:4494–504.CrossRef
34.
Zurück zum Zitat De Luca M, Tie T, Ooi G, et al. Mini gastric bypass-one anastomosis gastric bypass (MGB-OAGB)—IFSO position statement. Obes Surg. 2018;28:1188–206.CrossRef De Luca M, Tie T, Ooi G, et al. Mini gastric bypass-one anastomosis gastric bypass (MGB-OAGB)—IFSO position statement. Obes Surg. 2018;28:1188–206.CrossRef
35.
Zurück zum Zitat De Luca M, Angrisani L, Himpens J, Busetto L, Scopinaro N, Weiner R, et al. Indications for surgery for obesity and weight-related diseases: position statements from the International Federation for the Surgery of Obesity and metabolic disorders (IFSO). Obes Surg. Obesity Surgery; 2016;26:1659–96. Available from: https://doi.org/10.1007/s11695-016-2271-4. De Luca M, Angrisani L, Himpens J, Busetto L, Scopinaro N, Weiner R, et al. Indications for surgery for obesity and weight-related diseases: position statements from the International Federation for the Surgery of Obesity and metabolic disorders (IFSO). Obes Surg. Obesity Surgery; 2016;26:1659–96. Available from: https://​doi.​org/​10.​1007/​s11695-016-2271-4.
36.
Zurück zum Zitat Keleidari B, Mahmoudieh M, Kafi S, Shahabi S, Sheikhbahaei E, Farahmand A, et al. Which one is better for non-alcoholic fatty liver disease, the Roux-en-Y gastric bypass or one anastomosis gastric bypass? A paired liver biopsy report. Obes Med. Elsevier Ltd; 2020;18:100205. Available from: https://doi.org/10.1016/j.obmed.2020.100205. Keleidari B, Mahmoudieh M, Kafi S, Shahabi S, Sheikhbahaei E, Farahmand A, et al. Which one is better for non-alcoholic fatty liver disease, the Roux-en-Y gastric bypass or one anastomosis gastric bypass? A paired liver biopsy report. Obes Med. Elsevier Ltd; 2020;18:100205. Available from: https://​doi.​org/​10.​1016/​j.​obmed.​2020.​100205.
37.
Zurück zum Zitat Mahmoudieh M, Keleidari B, Afshin N, et al. The early results of the laparoscopic mini-gastric bypass/one anastomosis gastric bypass on patients with different body mass index. J Obes. 2020;2020:1–6.CrossRef Mahmoudieh M, Keleidari B, Afshin N, et al. The early results of the laparoscopic mini-gastric bypass/one anastomosis gastric bypass on patients with different body mass index. J Obes. 2020;2020:1–6.CrossRef
39.
Zurück zum Zitat American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2015;38:S8-16. American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2015;38:S8-16.
40.
Zurück zum Zitat Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–219.CrossRef Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–219.CrossRef
41.
Zurück zum Zitat Sadeghi M, Golshahi J, Talaei M, Sheikhbahaei E, Ghodjani E, Mansouri M, et al. 15-Year lipid profile effects on cardiovascular events adjusted for cardiovascular risk factors: a cohort study from Middle-East. Acta Cardiol. Taylor & Francis; 2020;0:1–6. Available from: https://doi.org/10.1080/00015385.2020.1717096. Sadeghi M, Golshahi J, Talaei M, Sheikhbahaei E, Ghodjani E, Mansouri M, et al. 15-Year lipid profile effects on cardiovascular events adjusted for cardiovascular risk factors: a cohort study from Middle-East. Acta Cardiol. Taylor & Francis; 2020;0:1–6. Available from: https://​doi.​org/​10.​1080/​00015385.​2020.​1717096.
42.
Zurück zum Zitat Michels WM, Grootendorst DC, Verduijn M, et al. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol. 2010;5:1003–9.CrossRef Michels WM, Grootendorst DC, Verduijn M, et al. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol. 2010;5:1003–9.CrossRef
44.
Zurück zum Zitat Neff KJ, Baud G, Raverdy V, Caiazzo R, Verkindt H, Noel C, et al. Renal function and Remission of hypertension after bariatric surgery: a 5-year prospective cohort study. Obes Surg. Obesity Surgery; 2017;27:613–9. Available from: https://doi.org/10.1007/s11695-016-2333-7. Neff KJ, Baud G, Raverdy V, Caiazzo R, Verkindt H, Noel C, et al. Renal function and Remission of hypertension after bariatric surgery: a 5-year prospective cohort study. Obes Surg. Obesity Surgery; 2017;27:613–9. Available from: https://​doi.​org/​10.​1007/​s11695-016-2333-7.
45.
Zurück zum Zitat Friedman AN, Cohen RV. Bariatric surgery as a renoprotective intervention. Curr Opin Nephrol Hypertens. 2019;28:537–44.CrossRef Friedman AN, Cohen RV. Bariatric surgery as a renoprotective intervention. Curr Opin Nephrol Hypertens. 2019;28:537–44.CrossRef
46.
Zurück zum Zitat Luaces M, Martínez-Martínez E, Medina M, et al. The impact of bariatric surgery on renal and cardiac functions in morbidly obese patients. Nephrol Dial Transplant. 2012;27:iv53–7.CrossRef Luaces M, Martínez-Martínez E, Medina M, et al. The impact of bariatric surgery on renal and cardiac functions in morbidly obese patients. Nephrol Dial Transplant. 2012;27:iv53–7.CrossRef
47.
Zurück zum Zitat Fenske WK, Dubb S, Bueter M, Seyfried F, Patel K, Tam FWK, et al. Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study. Surg Obes Relat Dis. American Society for Metabolic and Bariatric Surgery; 2013;9:559–68. Available from: https://doi.org/10.1016/j.soard.2012.03.009. Fenske WK, Dubb S, Bueter M, Seyfried F, Patel K, Tam FWK, et al. Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study. Surg Obes Relat Dis. American Society for Metabolic and Bariatric Surgery; 2013;9:559–68. Available from: https://​doi.​org/​10.​1016/​j.​soard.​2012.​03.​009.
48.
Zurück zum Zitat Bilha SC, Nistor I, Nedelcu A, et al. The effects of bariatric surgery on renal outcomes: a systematic review and meta-analysis. Obes Surg. 2018;28:3815–33.CrossRef Bilha SC, Nistor I, Nedelcu A, et al. The effects of bariatric surgery on renal outcomes: a systematic review and meta-analysis. Obes Surg. 2018;28:3815–33.CrossRef
49.
Zurück zum Zitat Navaneethan SD, Malin SK, Arrigain S, et al. Bariatric surgery, kidney function, insulin resistance, and adipokines in patients with decreased GFR: A cohort study. Am J Kidney Dis. 2015;65:345–7.CrossRef Navaneethan SD, Malin SK, Arrigain S, et al. Bariatric surgery, kidney function, insulin resistance, and adipokines in patients with decreased GFR: A cohort study. Am J Kidney Dis. 2015;65:345–7.CrossRef
52.
Zurück zum Zitat Li K, Zou J, Ye Z, et al. Effects of bariatric surgery on renal function in obese patients: a systematic review and meta analysis. PLoS One. 2016;11:1–18. Li K, Zou J, Ye Z, et al. Effects of bariatric surgery on renal function in obese patients: a systematic review and meta analysis. PLoS One. 2016;11:1–18.
Metadaten
Titel
Comparative Effectiveness of Roux-en-Y Gastric Bypass vs. One Anastomosis Gastric Bypass on Kidney Function
verfasst von
Mohsen Mahmoudieh
Behrouz Keleidari
Pedram Hadipour
Erfan Sheikhbahaei
Alex R. Chang
Sina Ramtin
Shahab Shahabi
Publikationsdatum
18.02.2021
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 6/2021
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-021-05295-z

Weitere Artikel der Ausgabe 6/2021

Obesity Surgery 6/2021 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.